Doorgaan naar hoofdcontent

Posts

Posts uit januari 10, 2023 tonen

Magazine Nationale Zorgklas

Magazine Nationale Zorgklas Magazine Nationale Zorgklas 10 januari 2023 - De Nationale Zorgklas ontstaan tijdens de Coronacrisis speelt in op de arbeidsmarktkrapte in de zorgsector door nieuw in te stromen medewerkers snel inzetbaar te maken voor ondersteuning in de zorg. Wil je het laatste nieuws in jouw mailbox ontvangen? Meld je dan aan voor de nieuwsbrief .

Human medicines European public assessment report (EPAR): Jcovden (previously COVID-19 Vaccine Janssen), COVID-19 vaccine (Ad26.COV2-S [recombinant]), COVID-19 virus infection, Date of authorisation: 11/03/2021, Revision: 26, Status: Authorised

Human medicines European public assessment report (EPAR): Jcovden (previously COVID-19 Vaccine Janssen), COVID-19 vaccine (Ad26.COV2-S [recombinant]), COVID-19 virus infection, Date of authorisation: 11/03/2021, Revision: 26, Status: Authorised Human medicines European public assessment report (EPAR): Jcovden (previously COVID-19 Vaccine Janssen), COVID-19 vaccine (Ad26.COV2-S [recombinant]), COVID-19 virus infection, Date of authorisation: 11/03/2021, Revision: 26, Status: Authorised Human medicines European public assessment report (EPAR): Jcovden (previously COVID-19 Vaccine Janssen), COVID-19 vaccine (Ad26.COV2-S [recombinant]), COVID-19 virus infection, Date of authorisation: 11/03/2021, Revision: 26, Status: Authorised

Human medicines European public assessment report (EPAR): Mimpara, cinacalcet, Hypercalcemia;Parathyroid Neoplasms;Hyperparathyroidism, Date of authorisation: 22/10/2004, Revision: 24, Status: Authorised

Human medicines European public assessment report (EPAR): Mimpara, cinacalcet, Hypercalcemia;Parathyroid Neoplasms;Hyperparathyroidism, Date of authorisation: 22/10/2004, Revision: 24, Status: Authorised Human medicines European public assessment report (EPAR): Mimpara, cinacalcet, Hypercalcemia;Parathyroid Neoplasms;Hyperparathyroidism, Date of authorisation: 22/10/2004, Revision: 24, Status: Authorised Human medicines European public assessment report (EPAR): Mimpara, cinacalcet, Hypercalcemia;Parathyroid Neoplasms;Hyperparathyroidism, Date of authorisation: 22/10/2004, Revision: 24, Status: Authorised Wil je het laatste nieuws in jouw mailbox ontvangen? Meld je